YoungEWhangMD
Oncology • Chapel Hill, NCGenitourinary Oncology
Associate Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Dr. Whang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-0000Fax+1 919-966-7772- Is this information wrong?
Education & Training
Ronald Reagan UCLA Medical CenterPost-Doctoral Fellowship, Clinical and Basic Science Research Fellowship, 1996 - 1998- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1990 - 1993
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1990, MD
Certifications & Licensure
NC State Medical License 1998 - 2025
CA State Medical License 1991 - 1998- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer Start of enrollment: 2009 May 01
- Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2012 Mar 30
- Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Real-World Incidence and Severity of Hypertension Caused by Abiraterone Acetate in Patients With Metastatic Prostate Cancer.Lam, B., Rodgers, J., Muluneh, B., Proco, D., Morgan, K., Whang, Y.> ;The Annals of Pharmacotherapy. 2024 Feb 12
- Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States.Rencsok, E., Slopen, N., McManus, H., Autio, K., Morgans, A., McSwain, L., Barata, P., Cheng, H., Dreicer, R., Gerke, T., Green, R., Heath, E., Howard, L., McKay, R., ...> ;Cancer Research Communications. 2024 Jan 8
- 1 citationsQuality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.Emily M Rencsok, Natalie Slopen, Karen Autio, Alicia Morgans, Lawrence McSwain, Pedro Barata, Heather H Cheng, Robert Dreicer, Elisabeth Heath, Rana R McKay, Mark Pome...> ;Quality of Life Research. 2023 Nov 1
- Join now to see all
Journal Articles
- Article ZFX Mediates Non-Canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate CancerYoung Whang, MD, ScienceDirect
Grant Support
- Regulation Of Androgen Receptor By HER-2 And Ack1 Tyrosine KinasesNational Cancer Institute2008–2012
- Functional Analysis Of PTEN In Prostate CancerNational Cancer Institute2000–2005
- Targeted Therapy Of Prostate CancerNational Cancer Institute2003–2004
Professional Memberships
- Member
Hospital Affiliations
University of North Carolina HospitalsChapel Hill, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
